As of May 1, 2025, our over 5,000 healthcare partners throughout the United States have dispensed over 2,000,000 units of our market leading Tolcylen® products. Additionally, two new products have been cleared for an early 4th quarter launch this year. The new products are expected to drive additional revenue growth from existing and new market specialties.